910 results on '"Gorbunova V"'
Search Results
202. A Randomized, Double-Blind, Phase 2 Trial of Veliparib (ABT-888) With Carboplatin and Paclitaxel in Previously Untreated Metastatic or Advanced Non-Small Cell Lung Cancer
203. Single Center Experience of Everolimus Combined with Long-Acting Octreotide in Patients (Pts) with Pretreated Advanced Well Differentiated Neuroendocrine Tumours (Nets) of Different Origin
204. Federal clinical practice guidelines on the diagnostics and treatment of adrenocortical cancer
205. Draft of Russian Guidelines of Diagnosis and Treatment of Adrenal Cortical Cancer
206. AKT overactivation can suppress DNA repair via p70S6 kinase-dependent downregulation of MRE11
207. Abstract P5-09-12: Novel role of proto-oncogene PELP1 in A-NHEJ pathway of double strand break repair: Implications for treatment of hormonal therapy resistance
208. Evaluation of Registration Methods on Thoracic CT: The EMPIRE10 Challenge
209. Reversibility of trapped air on CT scans of cystic fibrosis patients, an automated approach
210. Curve- and Surface-based Registration of Lung CT images via Currents
211. WHICH PATIENTS WITH OVARIAN CANCER SHOWS THE COMBINATION OF TRABECTEDIN WITH PEGYLATED LIPOSOMAL DOXORUBICIN
212. Combination of cisplatin/S-1 in the treatment of patients with advanced gastric or gastroesophageal adenocarcinoma: Results of noninferiority and safety analyses compared with cisplatin/5-fluorouracil in the First-Line Advanced Gastric Cancer Study
213. A human iPSC model of Ligase IV deficiency reveals an important role for NHEJ-mediated-DSB repair in the survival and genomic stability of induced pluripotent stem cells and emerging haematopoietic progenitors
214. CLINICAL CASE OF SUCCESSFUL LONG-TERM TREATMENT OF THE PATIENT WITH METASTATIC CERVICAL CANCER
215. Abstract OT3-3-01: Eniluracil + 5-fluorouracil + leucovorin (EFL) vs. capecitabine phase 2 trial for metastatic breast cancer
216. 1021 GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HEPATOCELLULAR CARCINOMA (HCC) AND OF ITS TREATMENT WITH SORAFENIB (GIDEON): IMPACT OF LIVER DYSFUNCTION ON SORAFENIB TREATMENT IN EUROPE
217. 1034 REAL-WORLD MANAGEMENT OF HCC WITH SORAFENIB AND TACE IN EUROPE FROM GIDEON (GLOBAL INVESTIGATION OF THERAPEUTIC DECISIONS IN HCC AND OF ITS TREATMENT WITH SORAFENIB)
218. 9003 ORAL Biomarker Analysis in BO21015, a Phase II Randomised Study of First-line Bevacizumab (BEV) Combined With Carboplatin-gemcitabine (CG) or Carboplatin-paclitaxel (CP) in Patients (pts) With Advanced or Recurrent Non-squamous Non-small Cell Lung Cancer (NSCLC)
219. 9076 POSTER An Interim Analysis of Health-Related Quality of Life (HRQoL) in Patients With Non-Squamous Non-Small-Cell Lung Cancer (nsNSCLC) Receiving Bevacizumab Vs Bevacizumab+Pemetrexed for Maintenance Therapy in AVAPERL 1
220. AVAPERL (MO22089): Final Efficacy Outcomes for Patients (pts) With Advanced Non-squamous Non-small Cell Lung Cancer (nsNSCLC) Randomised to Continuation Maintenance (mtc) with Bevacizumab (bev) or Bev + Pemetrexed (pern) After First-line (1L) Bev-cisplatin (cis)-pem Treatment (Tx)
221. SIRT6 Promotes DNA Repair Under Stress by Activating PARP1
222. 201* Reversibility of trapped air on CT scans of cystic fibrosis patients, an automated approach
223. AVAPERL1 (MO22089): Maintenance (mtc) bevacizumab (bev) with or without pemetrexed (pem) in patients (pts) with advanced nonsquamous non-small cell lung cancer (nsNSCLC) treated with first-line (1L) bev-cisplatin (cis)-pem: Interim safety data.
224. Gemcitabine plus cisplatin in patients with heavily pretreated advanced breast cancer with brain metastases.
225. Temozolomide therapy for patients with non-small cell lung cancer, breast cancer, or melanoma brain metastases.
226. Genetic polymorphisms and the efficacy and toxicity of cisplatin-based chemotherapy in ovarian cancer patients
227. Multicenter phase III comparison of cisplatin/S-1 (CS) with cisplatin/5-FU (CF) as first-line therapy in patients with advanced gastric cancer (FLAGS): Secondary and subset analyses
228. Comparison of nonhomologous end joining and homologous recombination in human cells
229. A randomised phase II study evaluating the combination of carboplatin-based chemotherapy with pertuzumab (P) versus carboplatin-based therapy alone in patients with relapsed, platinum sensitive ovarian cancer
230. Changes in DNA repair during aging
231. B1-06: Multicenter, randomized study of Docetaxel versus Docetaxel plus Oblimersen in patients previously treated for non-small cell lung cancer (NSCLC)
232. Lung CT registration combining intensity, curves and surfaces.
233. 1149P - Single Center Experience of Everolimus Combined with Long-Acting Octreotide in Patients (Pts) with Pretreated Advanced Well Differentiated Neuroendocrine Tumours (Nets) of Different Origin
234. The thermal conductivity of F-4 PTFE at 5–310°K
235. Colloidal palladium: Photochemical production and optical properties
236. A separator with automatic precipitate discharge for electrolyte clarification
237. Randomized open-label phase III multicenter trial comparing TAXOL®/doxorubicin (AT) versus 5-fluorouracil/doxorubicin and cyclophosphamide (FAC) as a first line treatment for patients with metastatic breast cancer
238. Non-homologous DNA end joining in plant cells is associated with deletions and filler DNA insertions
239. Pharmacogenomics of cisplatin-based chemotherapy in ovarian-cancer patients from Yakutia.
240. Photochemical synthesis of silver and gold nanoparticles in polyhydric alcohols.
241. Dystrophin gene analysis and prenatal diagnosis of Duchenne muscular dystrophy in Russia
242. Calculation of the productivity of tubular centrifuges
243. Five years' experience of prenatal diagnosis of cystic fibrosis in the former U.S.S.R.
244. Relationship of structure to acute toxicity and antiarrhythmic activity in alkylamino- and dialkylaminoacet-ortho-toluidides
245. Synthesis, acute toxicity, and antiarrhythmic activity of orthosubstituted arylamides of morpholinoacetic acid
246. Aflibercept and Docetaxel Versus Docetaxel Alone After Platinum Failure in Patients With Advanced or Metastatic Non-Small-Cell Lung Cancer: A Randomized, Controlled Phase III Trial.
247. Effect of concentrations of silver(I) and gold(III) initial compounds on the properties of AgAu bimetal nanocages.
248. Synthesis of hollow bimetal particles based on silver and gold.
249. The problem of utilization of spent household batteries.
250. Safety and efficacy of first-line bevacizumab plus chemotherapy in elderly patients with advanced or recurrent nonsquamous non-small cell lung cancer: safety of avastin in lung trial (MO19390)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.